FUJIFILM and the National Breast Cancer Foundation Celebrate Installation of New State-of-the-Art Mammography Unit at The Rose

HOUSTON--The Rose, a Houston-based, non-profit breast health organization providing screening and diagnostic services to women, will celebrate the installation of a new, state-of-the-art mammography unit donated by FUJIFILM Medical Systems U.S.A., Inc. and the National Breast Cancer Foundation on August 7, 2013. A ribbon-cutting ceremony will unveil Fujifilm’s FCR Aspire ClearView 1m at The Rose that will help meet the screening needs of women and assist medical professionals in the early detection and diagnosis of breast cancer.

“We are delighted to be working with the National Breast Cancer Foundation and The Rose to make a contribution that will have both immediate and long-term impacts on improving breast health care in the Houston community,” said Betty Dedon, product and marketing manager, Women’s Health, FUJIFILM Medical Systems U.S.A., Inc.

Breast cancer is one of the leading health crises for women in the United States. There is currently no known cure yet and early detection is critical to treatment and survival. The Rose’s Mobile Mammography Program currently extends to 24 counties in Texas providing screenings to more than 7,300 women annually with almost 4,700 of those patients needing some sort of financial sponsorship. While the new equipment will initially be located at The Rose’s southeast facility, its intended destination is in the next mobile health van purchased.

“The need for The Rose’s mobile program, which already reaches so many underserved areas, is evident now and will only grow,” Dorothy Gibbons, CEO and Co-Founder of The Rose, a nonprofit breast health organization providing screening and diagnostic services to the insured and uninsured in southeast Texas. “Donations like Fujifilm’s FCR Aspire ClearView 1m, made possible because of the generosity of the National Breast Cancer Foundation, will help us expand our mobile fleet and allow us to continue to provide quality breast health care to those who might otherwise have no access to screening.”

According to a study published in the American Journal of Preventive Medicine, half of all counties based in Texas do not have access to a mammogram facility. Counties without facilities have large minority populations and are predominantly located in medically underserved rural areas. Populations in these areas without facilities were less affluent and less likely to have healthcare insurance. The study suggests that delivering mammography-screening services in the county of residence may benefit women who are currently underserved.

“Fujifilm is committed to investing in research and developing innovative imaging technologies that play a key role in the screening, detection and diagnosis of breast cancer,” said NBCF founder and CEO Janelle Hail. “Their support allows us to continue our mission - saving lives through early detection and providing mammograms to those in need.”

To learn more about Fujifilm’s women’s health care products, please visit http:\\aspire.fujimed.com.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc., supplies high quality, technologically advanced, FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information visit www.fujimed.com and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 10 companies around the world granted U.S. patents in 2012, and in the year ended March 31, 2013, had global revenues of $26.7 billion*. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.

* At an exchange rate of 83 yen to the dollar.